Can PVR be Prevented?
By: Marc J. Spirn, MD
A surgeon suggests three levels of prophylaxis
Intra-arterial Chemotherapy for Retinoblastoma
By: S. K. Steven Houston, III, MD; Timothy G. Murray, MD, MBA; Cristina E. Fernandes, MD; Mohammad A. Aziz-Sultan, MD
A promising treatment modality, with eyes and lives being saved
Stem Cell Therapy in Retinal Diseases
By: Tim U. Krohne, MD, FEBO
Current preclinical research results and upcoming clinical trials
Developing Effective Steroid/Anti-VEGF Combination Therapy Regimens
By: Michael A. Singer, MD
Recent additions to our therapeutic options have yielded new opportunities
Macula 2011: Highlights From the Conference
By: Andrew E. Mathis, PhD, Medical Editor
Wills Eye's 50-year-old Retina Service hosts
Ophthalmic OCT Reaches $1 Billion Per Year
By: Eric A. Swanson, MS; David Huang, M.D., Ph.D.
But reimbursement clampdown clouds future innovation
The Case for Navigated Retinal Laser Therapy
By: Marcus Kernt, MD
Navilas offers increased accuracy and reduced patient pain when treating DME
Upfront: From the Editor-in-Chief
By: Jason S. Slakter, M.D.
CATT out of the bag
Subspecialty News
Selected highlights from ARVO presentations: Antibiotic after intravitreal injection? New concepts in sustained-release drugs; Predicting macular hole surgery; CATT study, and more
Journal Club
New and noteworthy studies
Innovation in Retina
By: Jerry Helzner, Senior Editor; Emmett T. Cunningham, Jr., MD, PhD, MPH; Pravin U. Dugel, MD
Mark S. Blumenkranz: A Series of Successes
Coding Q&A
By: Riva Lee Asbell
Rules for scribing and extended ophthalmoscopy
Focus On
By: Samantha Stahl, Assistant Editor
The Merlin surgical viewing system